Serveur d'exploration sur l'Université de Trèves

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Musk ketone enhances benzo(a)pyrene induced mutagenicity in human derived Hep G2 cells

Identifieur interne : 001505 ( Istex/Corpus ); précédent : 001504; suivant : 001506

Musk ketone enhances benzo(a)pyrene induced mutagenicity in human derived Hep G2 cells

Auteurs : Volker Mersch-Sundermann ; Heidi Schneider ; Christian Freywald ; Cornelia Jenter ; Wolfram Parzefall ; Siegfried Knasmüller

Source :

RBID : ISTEX:1F861B2B2A2AD2EAEADEBDCB70FE9FEB7524F0E9

English descriptors

Abstract

Musk ketone is a widely used artificial fragrance which has been identified in human fatty tissue and milk. The mutagenic and comutagenic effects of this compound were studied in micronucleus tests with a human derived hepatoma cell line (Hep G2). Exposure of the cells to MK alone in the range between 5 and 5000ng/ml did not cause induction of MN. When the cells were treated simultaneously with MK (5–5000ng/ml) and 0.2μg/ml benzo(a)pyrene, no synergistic effects were detected; benzo(a)pyrene (B(a)P) itself caused an 1.5-fold increase of MN over the spontaneous background frequency (60 versus 39 MN/1000 binucleated cells). In a third experimental series, the cells were pretreated with MK for 28h and subsequently exposed to 0.2μg/ml B(a)P. In this case, a pronounced comutagenic effect was observed: The LOAEL for MK was 0.05μg/ml. With higher doses (0.5, 1.0 and 5.0μg MK/ml), a significant increase of B(a)P induced MN frequencies was measured, the induction rates being 50, 66, and 88%, respectively. Additional measurements of 7-ethoxyresorufin deethylase indicated that MK induces cytochrome P450 isoenzymes (1A1) which play a key role in the activation of B(a)P. The results of the present study show that MK amplifies the genotoxic effects of B(a)P in human derived cells and indicate that exposure of humans to MK might increase their susceptibility to the health hazards of B(a)P and other polycyclic aromatic hydrocarbons.

Url:
DOI: 10.1016/S1383-5718(01)00202-9

Links to Exploration step

ISTEX:1F861B2B2A2AD2EAEADEBDCB70FE9FEB7524F0E9

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Musk ketone enhances benzo(a)pyrene induced mutagenicity in human derived Hep G2 cells</title>
<author>
<name sortKey="Mersch Sundermann, Volker" sort="Mersch Sundermann, Volker" uniqKey="Mersch Sundermann V" first="Volker" last="Mersch-Sundermann">Volker Mersch-Sundermann</name>
<affiliation>
<mods:affiliation>E-mail: mersch@rumms.uni-mannheim.de</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Toxicology and Ecotoxicology, FB VI, University of Trier, 54286 Trier, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Schneider, Heidi" sort="Schneider, Heidi" uniqKey="Schneider H" first="Heidi" last="Schneider">Heidi Schneider</name>
<affiliation>
<mods:affiliation>Faculty of Clinical Medicine Mannheim, Institute of Microbiology and Hygiene, University of Heidelberg, P.O. Box 100023, D-68135 Mannheim, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Freywald, Christian" sort="Freywald, Christian" uniqKey="Freywald C" first="Christian" last="Freywald">Christian Freywald</name>
<affiliation>
<mods:affiliation>Institute of Cancer Research, University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Jenter, Cornelia" sort="Jenter, Cornelia" uniqKey="Jenter C" first="Cornelia" last="Jenter">Cornelia Jenter</name>
<affiliation>
<mods:affiliation>Faculty of Clinical Medicine Mannheim, Institute of Microbiology and Hygiene, University of Heidelberg, P.O. Box 100023, D-68135 Mannheim, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Parzefall, Wolfram" sort="Parzefall, Wolfram" uniqKey="Parzefall W" first="Wolfram" last="Parzefall">Wolfram Parzefall</name>
<affiliation>
<mods:affiliation>Faculty of Clinical Medicine Mannheim, Institute of Microbiology and Hygiene, University of Heidelberg, P.O. Box 100023, D-68135 Mannheim, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Knasmuller, Siegfried" sort="Knasmuller, Siegfried" uniqKey="Knasmuller S" first="Siegfried" last="Knasmüller">Siegfried Knasmüller</name>
<affiliation>
<mods:affiliation>Institute of Cancer Research, University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:1F861B2B2A2AD2EAEADEBDCB70FE9FEB7524F0E9</idno>
<date when="2001" year="2001">2001</date>
<idno type="doi">10.1016/S1383-5718(01)00202-9</idno>
<idno type="url">https://api.istex.fr/document/1F861B2B2A2AD2EAEADEBDCB70FE9FEB7524F0E9/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001505</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001505</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Musk ketone enhances benzo(a)pyrene induced mutagenicity in human derived Hep G2 cells</title>
<author>
<name sortKey="Mersch Sundermann, Volker" sort="Mersch Sundermann, Volker" uniqKey="Mersch Sundermann V" first="Volker" last="Mersch-Sundermann">Volker Mersch-Sundermann</name>
<affiliation>
<mods:affiliation>E-mail: mersch@rumms.uni-mannheim.de</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Toxicology and Ecotoxicology, FB VI, University of Trier, 54286 Trier, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Schneider, Heidi" sort="Schneider, Heidi" uniqKey="Schneider H" first="Heidi" last="Schneider">Heidi Schneider</name>
<affiliation>
<mods:affiliation>Faculty of Clinical Medicine Mannheim, Institute of Microbiology and Hygiene, University of Heidelberg, P.O. Box 100023, D-68135 Mannheim, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Freywald, Christian" sort="Freywald, Christian" uniqKey="Freywald C" first="Christian" last="Freywald">Christian Freywald</name>
<affiliation>
<mods:affiliation>Institute of Cancer Research, University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Jenter, Cornelia" sort="Jenter, Cornelia" uniqKey="Jenter C" first="Cornelia" last="Jenter">Cornelia Jenter</name>
<affiliation>
<mods:affiliation>Faculty of Clinical Medicine Mannheim, Institute of Microbiology and Hygiene, University of Heidelberg, P.O. Box 100023, D-68135 Mannheim, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Parzefall, Wolfram" sort="Parzefall, Wolfram" uniqKey="Parzefall W" first="Wolfram" last="Parzefall">Wolfram Parzefall</name>
<affiliation>
<mods:affiliation>Faculty of Clinical Medicine Mannheim, Institute of Microbiology and Hygiene, University of Heidelberg, P.O. Box 100023, D-68135 Mannheim, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Knasmuller, Siegfried" sort="Knasmuller, Siegfried" uniqKey="Knasmuller S" first="Siegfried" last="Knasmüller">Siegfried Knasmüller</name>
<affiliation>
<mods:affiliation>Institute of Cancer Research, University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Mutation Research - Genetic Toxicology and Environmental Mutagenesis</title>
<title level="j" type="abbrev">MUTGEN</title>
<idno type="ISSN">1383-5718</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="2001">2001</date>
<biblScope unit="volume">495</biblScope>
<biblScope unit="issue">1–2</biblScope>
<biblScope unit="page" from="89">89</biblScope>
<biblScope unit="page" to="96">96</biblScope>
</imprint>
<idno type="ISSN">1383-5718</idno>
</series>
<idno type="istex">1F861B2B2A2AD2EAEADEBDCB70FE9FEB7524F0E9</idno>
<idno type="DOI">10.1016/S1383-5718(01)00202-9</idno>
<idno type="PII">S1383-5718(01)00202-9</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1383-5718</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>AC, Arochlor 1254</term>
<term>B(a)P, benzo(a)pyrene</term>
<term>BNC, binucleated cell</term>
<term>Benzo(a)pyrene</term>
<term>Comutagenic</term>
<term>DMEM, Dulbeccos minimal essential medium</term>
<term>DMSO, dimethylsulfoxide</term>
<term>EROD, 7-ethoxyresorufin-O-deethylase</term>
<term>GST, glutathione-S-transferase</term>
<term>Hep G2/MN assay</term>
<term>LOAEL, lowest observed adverse effect level</term>
<term>M, mean</term>
<term>MK, musk ketone</term>
<term>MN, micronucleus</term>
<term>Musk ketone</term>
<term>NM, nitro musk</term>
<term>PAH, polycyclic aromatic hydrocarbon</term>
<term>PB, phenobarbital</term>
<term>S.D., standard deviation</term>
<term>UDPGT, uridine-diphosphate-glucuronyl-transferase</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Musk ketone is a widely used artificial fragrance which has been identified in human fatty tissue and milk. The mutagenic and comutagenic effects of this compound were studied in micronucleus tests with a human derived hepatoma cell line (Hep G2). Exposure of the cells to MK alone in the range between 5 and 5000ng/ml did not cause induction of MN. When the cells were treated simultaneously with MK (5–5000ng/ml) and 0.2μg/ml benzo(a)pyrene, no synergistic effects were detected; benzo(a)pyrene (B(a)P) itself caused an 1.5-fold increase of MN over the spontaneous background frequency (60 versus 39 MN/1000 binucleated cells). In a third experimental series, the cells were pretreated with MK for 28h and subsequently exposed to 0.2μg/ml B(a)P. In this case, a pronounced comutagenic effect was observed: The LOAEL for MK was 0.05μg/ml. With higher doses (0.5, 1.0 and 5.0μg MK/ml), a significant increase of B(a)P induced MN frequencies was measured, the induction rates being 50, 66, and 88%, respectively. Additional measurements of 7-ethoxyresorufin deethylase indicated that MK induces cytochrome P450 isoenzymes (1A1) which play a key role in the activation of B(a)P. The results of the present study show that MK amplifies the genotoxic effects of B(a)P in human derived cells and indicate that exposure of humans to MK might increase their susceptibility to the health hazards of B(a)P and other polycyclic aromatic hydrocarbons.</div>
</front>
</TEI>
<istex>
<corpusName>elsevier</corpusName>
<author>
<json:item>
<name>Volker Mersch-Sundermann</name>
<affiliations>
<json:string>E-mail: mersch@rumms.uni-mannheim.de</json:string>
<json:string>Department of Toxicology and Ecotoxicology, FB VI, University of Trier, 54286 Trier, Germany</json:string>
</affiliations>
</json:item>
<json:item>
<name>Heidi Schneider</name>
<affiliations>
<json:string>Faculty of Clinical Medicine Mannheim, Institute of Microbiology and Hygiene, University of Heidelberg, P.O. Box 100023, D-68135 Mannheim, Germany</json:string>
</affiliations>
</json:item>
<json:item>
<name>Christian Freywald</name>
<affiliations>
<json:string>Institute of Cancer Research, University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria</json:string>
</affiliations>
</json:item>
<json:item>
<name>Cornelia Jenter</name>
<affiliations>
<json:string>Faculty of Clinical Medicine Mannheim, Institute of Microbiology and Hygiene, University of Heidelberg, P.O. Box 100023, D-68135 Mannheim, Germany</json:string>
</affiliations>
</json:item>
<json:item>
<name>Wolfram Parzefall</name>
<affiliations>
<json:string>Faculty of Clinical Medicine Mannheim, Institute of Microbiology and Hygiene, University of Heidelberg, P.O. Box 100023, D-68135 Mannheim, Germany</json:string>
</affiliations>
</json:item>
<json:item>
<name>Siegfried Knasmüller</name>
<affiliations>
<json:string>Institute of Cancer Research, University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria</json:string>
</affiliations>
</json:item>
</author>
<subject>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>AC, Arochlor 1254</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>B(a)P, benzo(a)pyrene</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>BNC, binucleated cell</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>DMEM, Dulbeccos minimal essential medium</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>DMSO, dimethylsulfoxide</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>EROD, 7-ethoxyresorufin-O-deethylase</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>GST, glutathione-S-transferase</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>LOAEL, lowest observed adverse effect level</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>M, mean</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>MK, musk ketone</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>MN, micronucleus</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>NM, nitro musk</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>PAH, polycyclic aromatic hydrocarbon</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>PB, phenobarbital</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>S.D., standard deviation</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>UDPGT, uridine-diphosphate-glucuronyl-transferase</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Hep G2/MN assay</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Musk ketone</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Benzo(a)pyrene</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Comutagenic</value>
</json:item>
</subject>
<language>
<json:string>eng</json:string>
</language>
<originalGenre>
<json:string>Full-length article</json:string>
</originalGenre>
<abstract>Musk ketone is a widely used artificial fragrance which has been identified in human fatty tissue and milk. The mutagenic and comutagenic effects of this compound were studied in micronucleus tests with a human derived hepatoma cell line (Hep G2). Exposure of the cells to MK alone in the range between 5 and 5000ng/ml did not cause induction of MN. When the cells were treated simultaneously with MK (5–5000ng/ml) and 0.2μg/ml benzo(a)pyrene, no synergistic effects were detected; benzo(a)pyrene (B(a)P) itself caused an 1.5-fold increase of MN over the spontaneous background frequency (60 versus 39 MN/1000 binucleated cells). In a third experimental series, the cells were pretreated with MK for 28h and subsequently exposed to 0.2μg/ml B(a)P. In this case, a pronounced comutagenic effect was observed: The LOAEL for MK was 0.05μg/ml. With higher doses (0.5, 1.0 and 5.0μg MK/ml), a significant increase of B(a)P induced MN frequencies was measured, the induction rates being 50, 66, and 88%, respectively. Additional measurements of 7-ethoxyresorufin deethylase indicated that MK induces cytochrome P450 isoenzymes (1A1) which play a key role in the activation of B(a)P. The results of the present study show that MK amplifies the genotoxic effects of B(a)P in human derived cells and indicate that exposure of humans to MK might increase their susceptibility to the health hazards of B(a)P and other polycyclic aromatic hydrocarbons.</abstract>
<qualityIndicators>
<score>6.83</score>
<pdfVersion>1.2</pdfVersion>
<pdfPageSize>612 x 792 pts (letter)</pdfPageSize>
<refBibsNative>true</refBibsNative>
<keywordCount>20</keywordCount>
<abstractCharCount>1440</abstractCharCount>
<pdfWordCount>4154</pdfWordCount>
<pdfCharCount>25704</pdfCharCount>
<pdfPageCount>8</pdfPageCount>
<abstractWordCount>223</abstractWordCount>
</qualityIndicators>
<title>Musk ketone enhances benzo(a)pyrene induced mutagenicity in human derived Hep G2 cells</title>
<pii>
<json:string>S1383-5718(01)00202-9</json:string>
</pii>
<refBibs>
<json:item>
<author>
<json:item>
<name>J. Hahn</name>
</json:item>
</author>
<host>
<volume>89</volume>
<pages>
<last>177</last>
<first>175</first>
</pages>
<author></author>
<title>Deut. Lebensm.-Rundsch.</title>
</host>
<title>Untersuchungen zum Vorkommen von Xylol-Moschus in Fischen</title>
</json:item>
<json:item>
<author>
<json:item>
<name>H. Ippen</name>
</json:item>
</author>
<host>
<volume>94</volume>
<pages>
<last>260</last>
<first>255</first>
</pages>
<author></author>
<title>Bundesgesundhbl.</title>
</host>
<title>Nitromoschus. 1. Mitteilung</title>
</json:item>
<json:item>
<author>
<json:item>
<name>H. Ippen</name>
</json:item>
</author>
<host>
<volume>94</volume>
<pages>
<last>294</last>
<first>291</first>
</pages>
<author></author>
<title>Bundesgesundhbl.</title>
</host>
<title>Nitromoschus. 2. Mitteilung</title>
</json:item>
<json:item>
<author>
<json:item>
<name>K. Minegishi</name>
</json:item>
<json:item>
<name>S. Nambaru</name>
</json:item>
<json:item>
<name>M. Fukuoka</name>
</json:item>
<json:item>
<name>A. Tanaka</name>
</json:item>
<json:item>
<name>T. Nishimaki-Mogami</name>
</json:item>
</author>
<host>
<volume>65</volume>
<pages>
<last>282</last>
<first>273</first>
</pages>
<author></author>
<title>Arch. Toxicol.</title>
</host>
<title>Distribution, metabolism, and excretion of musk xylene in rats</title>
</json:item>
<json:item>
<author>
<json:item>
<name>J. Nair</name>
</json:item>
<json:item>
<name>H. Ohshima</name>
</json:item>
<json:item>
<name>C. Malaveille</name>
</json:item>
<json:item>
<name>M. Friesen</name>
</json:item>
<json:item>
<name>I.K. O’Neill</name>
</json:item>
<json:item>
<name>A. Hautefeuille</name>
</json:item>
<json:item>
<name>H. Bartsch</name>
</json:item>
</author>
<host>
<volume>24</volume>
<pages>
<last>31</last>
<first>27</first>
</pages>
<author></author>
<title>Food Chem. Toxicol.</title>
</host>
<title>Identification, occurence and mutagenicity in Salmonella typhimurium of two synthetic nitroarenes, musk ambrette and musk xylene, in indian chewing tobacco and betel quid</title>
</json:item>
<json:item>
<author>
<json:item>
<name>D.L. Opdyke</name>
</json:item>
</author>
<host>
<volume>13</volume>
<pages>
<last>876</last>
<first>875</first>
</pages>
<author></author>
<title>Food Cosm. Toxicol.</title>
</host>
<title>Musk ambrette</title>
</json:item>
<json:item>
<author>
<json:item>
<name>D.L. Opdyke</name>
</json:item>
</author>
<host>
<volume>13</volume>
<pages>
<last>878</last>
<first>877</first>
</pages>
<author></author>
<title>Food Cosm. Toxicol.</title>
</host>
<title>Musk ketone</title>
</json:item>
<json:item>
<author>
<json:item>
<name>D.L. Opdyke</name>
</json:item>
</author>
<host>
<volume>13</volume>
<pages>
<first>879</first>
</pages>
<author></author>
<title>Food Cosm. Toxicol.</title>
</host>
<title>Musk tibetene</title>
</json:item>
<json:item>
<author>
<json:item>
<name>D.L. Opdyke</name>
</json:item>
</author>
<host>
<volume>13</volume>
<pages>
<first>881</first>
</pages>
<author></author>
<title>Food Cosm. Toxicol.</title>
</host>
<title>Musk xylol</title>
</json:item>
<json:item>
<author>
<json:item>
<name>D.L. Opdyke</name>
</json:item>
</author>
<host>
<volume>13</volume>
<pages>
<first>885</first>
</pages>
<author></author>
<title>Food Cosm. Toxicol.</title>
</host>
<title>1,1,3,3,5-pentamethyl-4,6-dinitroindane</title>
</json:item>
<json:item>
<author>
<json:item>
<name>B. Liebl</name>
</json:item>
<json:item>
<name>S. Ehrenstorfer</name>
</json:item>
</author>
<host>
<volume>27</volume>
<pages>
<last>2255</last>
<first>2253</first>
</pages>
<author></author>
<title>Chemosphere</title>
</host>
<title>Nitro musks in human milk</title>
</json:item>
<json:item>
<author>
<json:item>
<name>T. Yamagishi</name>
</json:item>
<json:item>
<name>T. Miyazaki</name>
</json:item>
<json:item>
<name>S. Horii</name>
</json:item>
<json:item>
<name>K. Akiyama</name>
</json:item>
</author>
<host>
<volume>12</volume>
<pages>
<last>89</last>
<first>83</first>
</pages>
<author></author>
<title>Arch. Environ. Contam. Toxicol.</title>
</host>
<title>Synthetic musk residues in biota and water from Tama River and Tokyo Bay (Japan)</title>
</json:item>
<json:item>
<author>
<json:item>
<name>T. Yamagishi</name>
</json:item>
<json:item>
<name>T. Miyazaki</name>
</json:item>
<json:item>
<name>S. Horii</name>
</json:item>
<json:item>
<name>S. Kaneko</name>
</json:item>
</author>
<host>
<volume>26</volume>
<pages>
<last>662</last>
<first>656</first>
</pages>
<author></author>
<title>Bull. Environ. Contam. Toxicol.</title>
</host>
<title>Identification of musk ketone in freshwater fish collected from the Tama River, Tokyo</title>
</json:item>
<json:item>
<author>
<json:item>
<name>G. Rimkus</name>
</json:item>
<json:item>
<name>M. Wolf</name>
</json:item>
</author>
<host>
<volume>89</volume>
<pages>
<last>175</last>
<first>171</first>
</pages>
<author></author>
<title>Dt. Lebensm. Rdsch.</title>
</host>
<title>Rückstände und Verunreinigungen in Fischen aus Aquakultur</title>
</json:item>
<json:item>
<host>
<author></author>
</host>
</json:item>
<json:item>
<author>
<json:item>
<name>V. Mersch-Sundermann</name>
</json:item>
<json:item>
<name>V. Hanf</name>
</json:item>
<json:item>
<name>C. Leitzmann</name>
</json:item>
<json:item>
<name>H.-M. Melbuch</name>
</json:item>
<json:item>
<name>H. Lilienthal</name>
</json:item>
<json:item>
<name>S. Böse-O’Reilly</name>
</json:item>
</author>
<host>
<volume>39</volume>
<pages>
<last>696</last>
<first>683</first>
</pages>
<author></author>
<title>Internist. Prax.</title>
</host>
<title>Fremdstoffe in Frauenmilch</title>
</json:item>
<json:item>
<author>
<json:item>
<name>G. Rimkus</name>
</json:item>
<json:item>
<name>B. Rimkus</name>
</json:item>
<json:item>
<name>M. Wolf</name>
</json:item>
</author>
<host>
<volume>28</volume>
<pages>
<last>432</last>
<first>421</first>
</pages>
<author></author>
<title>Chemosphere</title>
</host>
<title>Nitro musks in human adipose tissue and breast milk</title>
</json:item>
<json:item>
<author>
<json:item>
<name>M. Emig</name>
</json:item>
<json:item>
<name>A. Reinhardt</name>
</json:item>
<json:item>
<name>V. Mersch-Sundermann</name>
</json:item>
</author>
<host>
<volume>85</volume>
<pages>
<last>156</last>
<first>151</first>
</pages>
<author></author>
<title>Toxicol. Lett.</title>
</host>
<title>A comparative study of five nitro musk compounds for genotoxicity in the SOS chromotest and Salmonella mutagenicity</title>
</json:item>
<json:item>
<author>
<json:item>
<name>S. Kevekordes</name>
</json:item>
<json:item>
<name>A. Zaulig</name>
</json:item>
<json:item>
<name>H. Dunkelberg</name>
</json:item>
</author>
<host>
<volume>91</volume>
<pages>
<last>17</last>
<first>13</first>
</pages>
<author></author>
<title>Toxicol. Lett.</title>
</host>
<title>Genotoxicity of nitro musks in the micronucleus test with human lymphocytes in vitro and the human hepatoma cell line Hep G2</title>
</json:item>
<json:item>
<author>
<json:item>
<name>V. Mersch-Sundermann</name>
</json:item>
<json:item>
<name>A. Reinhardt</name>
</json:item>
<json:item>
<name>M. Emig</name>
</json:item>
</author>
<host>
<volume>198</volume>
<pages>
<last>442</last>
<first>429</first>
</pages>
<author></author>
<title>Zbl. Hyg.</title>
</host>
<title>Examination of mutagenicity, genotoxicity, and cogenotoxicity of nitro musks in the environment</title>
</json:item>
<json:item>
<author>
<json:item>
<name>V. Mersch-Sundermann</name>
</json:item>
<json:item>
<name>M. Emig</name>
</json:item>
<json:item>
<name>A. Reinhardt</name>
</json:item>
<json:item>
<name>S. Kevekordes</name>
</json:item>
</author>
<host>
<volume>15/5A</volume>
<pages>
<last>1654</last>
<first>1653</first>
</pages>
<author></author>
<title>Anticancer Res.</title>
</host>
<title>DNA-damage, micronucleus formation and P450 enzyme induction by nitro musks</title>
</json:item>
<json:item>
<author>
<json:item>
<name>V. Mersch-Sundermann</name>
</json:item>
<json:item>
<name>M. Emig</name>
</json:item>
<json:item>
<name>A. Reinhardt</name>
</json:item>
</author>
<host>
<volume>356</volume>
<pages>
<last>245</last>
<first>237</first>
</pages>
<author></author>
<title>Mutat. Res.</title>
</host>
<title>Nitro musks are cogenotoxicants by inducing toxifying enzymes in the rat</title>
</json:item>
<json:item>
<author>
<json:item>
<name>N. Iwata</name>
</json:item>
<json:item>
<name>K. Minegishi</name>
</json:item>
<json:item>
<name>K. Suzuki</name>
</json:item>
<json:item>
<name>Y. Ohno</name>
</json:item>
<json:item>
<name>T. Igarashi</name>
</json:item>
<json:item>
<name>T. Satoh</name>
</json:item>
<json:item>
<name>T. Takahashi</name>
</json:item>
</author>
<host>
<volume>45</volume>
<pages>
<last>1665</last>
<first>1659</first>
</pages>
<author></author>
<title>Biochem. Pharmacol.</title>
</host>
<title>An unusual profile of musk xylene induced drug metabolizing enzymes in rat liver</title>
</json:item>
<json:item>
<author>
<json:item>
<name>N. Iwata</name>
</json:item>
<json:item>
<name>K. Minegishi</name>
</json:item>
<json:item>
<name>K. Suzuki</name>
</json:item>
<json:item>
<name>Y. Ohno</name>
</json:item>
<json:item>
<name>T. Kawanishi</name>
</json:item>
<json:item>
<name>T. Takahashi</name>
</json:item>
</author>
<host>
<volume>184</volume>
<pages>
<last>153</last>
<first>149</first>
</pages>
<author></author>
<title>Biochem. Biophys. Res. Commun.</title>
</host>
<title>Musk xylene is a novel specific inducer of cytochrome P450IA2</title>
</json:item>
<json:item>
<author>
<json:item>
<name>L.D. Lehman-McKeeman</name>
</json:item>
<json:item>
<name>D. Caudill</name>
</json:item>
<json:item>
<name>J.A. Young</name>
</json:item>
<json:item>
<name>T.A. Dierckman</name>
</json:item>
</author>
<host>
<volume>206</volume>
<pages>
<last>980</last>
<first>975</first>
</pages>
<author></author>
<title>Biochem. Biophys. Res. Commun.</title>
</host>
<title>Musk xylene induces and inhibits mouse hepatic cytochrome P-450 2B enzymes</title>
</json:item>
<json:item>
<author>
<json:item>
<name>M. Hall</name>
</json:item>
<json:item>
<name>L.M. Forrester</name>
</json:item>
<json:item>
<name>D.K. Parker</name>
</json:item>
<json:item>
<name>P.L. Grover</name>
</json:item>
<json:item>
<name>C.R. Wolf</name>
</json:item>
</author>
<host>
<volume>10</volume>
<pages>
<last>1821</last>
<first>1815</first>
</pages>
<author></author>
<title>Carcinogenesis</title>
</host>
<title>Relative contribution of various forms of cytochrome P450 to the metabolism of benzo(a)pyrene by human liver microsomes</title>
</json:item>
<json:item>
<host>
<author></author>
</host>
</json:item>
<json:item>
<author>
<json:item>
<name>I. Chung</name>
</json:item>
<json:item>
<name>E. Bresnick</name>
</json:item>
</author>
<host>
<volume>314</volume>
<pages>
<last>81</last>
<first>75</first>
</pages>
<author></author>
<title>Arch. Biochem. Biophys.</title>
</host>
<title>3-Methylcholanthrene-mediated induction of cytochrome P4501A2 in human hepatoma Hep G2 cells as quantified by the reverse transcription-polymerase chain reaction</title>
</json:item>
<json:item>
<author>
<json:item>
<name>C. Delescluse</name>
</json:item>
<json:item>
<name>N. Ledirac</name>
</json:item>
<json:item>
<name>G. de Sousa</name>
</json:item>
<json:item>
<name>M. Pralavorio</name>
</json:item>
<json:item>
<name>P. Lesca</name>
</json:item>
<json:item>
<name>R. Rahmani</name>
</json:item>
</author>
<host>
<volume>96/97</volume>
<pages>
<last>39</last>
<first>33</first>
</pages>
<author></author>
<title>Toxicol. Lett.</title>
</host>
<title>Cytotoxic effects and induction of cytochromes P450 1A1/2 by insecticides, in hepatic or epidermal cells: binding capability to the Ah receptor</title>
</json:item>
<json:item>
<author>
<json:item>
<name>H. Doostar</name>
</json:item>
<json:item>
<name>M.E. Grant</name>
</json:item>
<json:item>
<name>W.T. Melvin</name>
</json:item>
<json:item>
<name>C.R. Wolf</name>
</json:item>
<json:item>
<name>M.D. Burke</name>
</json:item>
</author>
<host>
<volume>46</volume>
<pages>
<last>635</last>
<first>629</first>
</pages>
<author></author>
<title>Biochem. Pharmacol.</title>
</host>
<title>The effects of inducing agents on cytochrome P450 and UDP-glucuronosyltransferase activities in human Hep G2 hepatoma cells</title>
</json:item>
<json:item>
<author>
<json:item>
<name>M.H. Grant</name>
</json:item>
<json:item>
<name>S.J. Duthie</name>
</json:item>
<json:item>
<name>A.G. Gray</name>
</json:item>
<json:item>
<name>M.D. Burke</name>
</json:item>
</author>
<host>
<volume>37</volume>
<pages>
<last>4116</last>
<first>4111</first>
</pages>
<author></author>
<title>Biochem. Pharmacol.</title>
</host>
<title>Mixed function oxidase and UDP-glucuronosyltransferase activities in the human Hep G2 hepatoma cell line</title>
</json:item>
<json:item>
<author>
<json:item>
<name>S. Kress</name>
</json:item>
<json:item>
<name>W.F. Greenlee</name>
</json:item>
</author>
<host>
<volume>57</volume>
<pages>
<last>1269</last>
<first>1264</first>
</pages>
<author></author>
<title>Cancer Res.</title>
</host>
<title>Cell-specific regulation of human CYP1A1 and CYP1B1 genes</title>
</json:item>
<json:item>
<author>
<json:item>
<name>S. Krusekopf</name>
</json:item>
<json:item>
<name>U. Kleeberg</name>
</json:item>
<json:item>
<name>A.G. Hildebrandt</name>
</json:item>
<json:item>
<name>K. Ruckpaul</name>
</json:item>
</author>
<host>
<volume>27</volume>
<pages>
<last>9</last>
<first>1</first>
</pages>
<author></author>
<title>Xenobiotica</title>
</host>
<title>Effects of benzimidazole derivatives on cytochrome P450 1A1 expression in a human hepatoma cell line</title>
</json:item>
<json:item>
<author>
<json:item>
<name>H. Babich</name>
</json:item>
<json:item>
<name>M.K. Sardana</name>
</json:item>
<json:item>
<name>E. Borenfreund</name>
</json:item>
</author>
<host>
<volume>4</volume>
<pages>
<last>309</last>
<first>295</first>
</pages>
<author></author>
<title>Cell Biol. Toxicol.</title>
</host>
<title>Acute cytotoxicities of polynuclear aromatic hydrocarbons determined in vitro with the human liver tumor cell line, Hep G2</title>
</json:item>
<json:item>
<author>
<json:item>
<name>S. Knasmüller</name>
</json:item>
<json:item>
<name>W. Parzefall</name>
</json:item>
<json:item>
<name>R. Sanyal</name>
</json:item>
<json:item>
<name>G. Williamson</name>
</json:item>
<json:item>
<name>S. Ecker</name>
</json:item>
<json:item>
<name>C. Schwab</name>
</json:item>
<json:item>
<name>M. Uhl</name>
</json:item>
<json:item>
<name>V. Mersch-Sundermann</name>
</json:item>
<json:item>
<name>G. Hietsch</name>
</json:item>
<json:item>
<name>T. Langer</name>
</json:item>
<json:item>
<name>F. Darroudi</name>
</json:item>
</author>
<host>
<volume>402</volume>
<pages>
<last>202</last>
<first>185</first>
</pages>
<author></author>
<title>Mutat. Res.</title>
</host>
<title>Use of metabolically competent human hepatoma cells for the detection of mutagens and antimutagens</title>
</json:item>
<json:item>
<author>
<json:item>
<name>A.T. Natarajan</name>
</json:item>
<json:item>
<name>F. Darroudi</name>
</json:item>
</author>
<host>
<volume>6</volume>
<pages>
<last>403</last>
<first>399</first>
</pages>
<author></author>
<title>Mutagenesis</title>
</host>
<title>Use of human hepatoma cells for in vitro metabolic activation of chemical mutagens/carcinogens</title>
</json:item>
<json:item>
<author>
<json:item>
<name>R.A. Lubet</name>
</json:item>
<json:item>
<name>R.W. Nims</name>
</json:item>
<json:item>
<name>R.T. Mayer</name>
</json:item>
<json:item>
<name>J.W. Cameron</name>
</json:item>
<json:item>
<name>L.M. Schechtmann</name>
</json:item>
</author>
<host>
<volume>142</volume>
<pages>
<last>131</last>
<first>127</first>
</pages>
<author></author>
<title>Mutat. Res.</title>
</host>
<title>Measurements of cytochrome P450 dependent dealkylation of alkoxyphenoxazones in hepatic S-9s and hepatic homogenates: effects of dicumarol</title>
</json:item>
<json:item>
<author>
<json:item>
<name>O.H. Lowry</name>
</json:item>
<json:item>
<name>N.J. Rosebrough</name>
</json:item>
<json:item>
<name>A.L. Farr</name>
</json:item>
<json:item>
<name>R.J. Randall</name>
</json:item>
</author>
<host>
<volume>193</volume>
<pages>
<last>275</last>
<first>265</first>
</pages>
<author></author>
<title>J. Biol. Chem.</title>
</host>
<title>Protein measurement with Folin–phenol reagent</title>
</json:item>
<json:item>
<author>
<json:item>
<name>A.M. Api</name>
</json:item>
<json:item>
<name>E.A. Pfitzer</name>
</json:item>
<json:item>
<name>R.H.C. San</name>
</json:item>
</author>
<host>
<volume>34</volume>
<pages>
<last>638</last>
<first>633</first>
</pages>
<author></author>
<title>Fd. Chem. Toxicol.</title>
</host>
<title>An evaluation of genotoxicity tests with musk ketone</title>
</json:item>
<json:item>
<author>
<json:item>
<name>S. Kevekordes</name>
</json:item>
<json:item>
<name>K. Grahl</name>
</json:item>
<json:item>
<name>A. Zaulig</name>
</json:item>
<json:item>
<name>H. Dunkelberg</name>
</json:item>
</author>
<host>
<volume>3</volume>
<pages>
<last>192</last>
<first>189</first>
</pages>
<author></author>
<title>Environ. Sci. Poll. Res.</title>
</host>
<title>Genotoxicity testing of nitro musks with the SOS chromotest and the sister-chromatid exchange test</title>
</json:item>
<json:item>
<author>
<json:item>
<name>S. Sassa</name>
</json:item>
<json:item>
<name>O. Sugita</name>
</json:item>
<json:item>
<name>R.A. Galbraith</name>
</json:item>
<json:item>
<name>A. Kappas</name>
</json:item>
</author>
<host>
<volume>143</volume>
<pages>
<last>57</last>
<first>52</first>
</pages>
<author></author>
<title>Biochem. Biophys. Res. Commun.</title>
</host>
<title>Drug metabolism by the human cell line Hep G2</title>
</json:item>
<json:item>
<author>
<json:item>
<name>C. Gerhäuser</name>
</json:item>
<json:item>
<name>M.Y. Jinfdang Liu</name>
</json:item>
<json:item>
<name>R.M. Moriarty</name>
</json:item>
<json:item>
<name>M. Hawthorne</name>
</json:item>
<json:item>
<name>R.G. Mehta</name>
</json:item>
<json:item>
<name>R.C. Moon</name>
</json:item>
<json:item>
<name>J.M. Pezzuto</name>
</json:item>
</author>
<host>
<volume>57</volume>
<pages>
<last>278</last>
<first>272</first>
</pages>
<author></author>
<title>Cancer Res.</title>
</host>
<title>Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes</title>
</json:item>
<json:item>
<author>
<json:item>
<name>T. Cresteil</name>
</json:item>
<json:item>
<name>P. Lesca</name>
</json:item>
</author>
<host>
<volume>47</volume>
<pages>
<last>156</last>
<first>145</first>
</pages>
<author></author>
<title>Chem. Biol. Interact.</title>
</host>
<title>Enhancement of DNA binding, mutagenicity and carcinogenicity of polycyclic aromatic hydrocarbons after induction of cytochrome P-450 by ellipticines in rats and mice</title>
</json:item>
</refBibs>
<genre>
<json:string>research-article</json:string>
</genre>
<host>
<volume>495</volume>
<pii>
<json:string>S1383-5718(00)X0071-X</json:string>
</pii>
<pages>
<last>96</last>
<first>89</first>
</pages>
<issn>
<json:string>1383-5718</json:string>
</issn>
<issue>1–2</issue>
<genre>
<json:string>journal</json:string>
</genre>
<language>
<json:string>unknown</json:string>
</language>
<title>Mutation Research - Genetic Toxicology and Environmental Mutagenesis</title>
<publicationDate>2001</publicationDate>
</host>
<categories>
<wos>
<json:string>science</json:string>
<json:string>toxicology</json:string>
<json:string>genetics & heredity</json:string>
<json:string>biotechnology & applied microbiology</json:string>
</wos>
<scienceMetrix>
<json:string>health sciences</json:string>
<json:string>biomedical research</json:string>
<json:string>toxicology</json:string>
</scienceMetrix>
</categories>
<publicationDate>2001</publicationDate>
<copyrightDate>2001</copyrightDate>
<doi>
<json:string>10.1016/S1383-5718(01)00202-9</json:string>
</doi>
<id>1F861B2B2A2AD2EAEADEBDCB70FE9FEB7524F0E9</id>
<score>0.6815407</score>
<fulltext>
<json:item>
<extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/document/1F861B2B2A2AD2EAEADEBDCB70FE9FEB7524F0E9/fulltext/pdf</uri>
</json:item>
<json:item>
<extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/document/1F861B2B2A2AD2EAEADEBDCB70FE9FEB7524F0E9/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/1F861B2B2A2AD2EAEADEBDCB70FE9FEB7524F0E9/fulltext/tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main" xml:lang="en">Musk ketone enhances benzo(a)pyrene induced mutagenicity in human derived Hep G2 cells</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>ELSEVIER</publisher>
<availability>
<p>©2001 Elsevier Science B.V.</p>
</availability>
<date>2001</date>
</publicationStmt>
<notesStmt>
<note type="content">Fig. 1: Chemical structure of musk ketone.</note>
<note type="content">Fig. 2: Induction of MN in Hep G2 cells by MK alone and in combination with B(a)P. Hep G2 cells were exposed (i) to different concentrations of MK for 28h (white bars), (ii) simultaneously to different MK concentrations and 0.2μg/ml B(a)P for 28h (hatched bars) or (iii) for 28h to different MK concentrations and subsequently to 0.2μg/ml B(a)P (black bars). After exposure, cells were cultivated for 24h in cytochalasin B supplemented medium, then the MN frequencies determined as described in the text. Three slides were prepared per experimental point and in total 1000 BNC were evaluated.</note>
<note type="content">Fig. 3: Effect of MK on the induction of EROD in Hep G2 cells: (a) the effect seen after exposure of the cells to different concentrations of MK; (b) the means±S.D. of three independent experiments in which the cells were exposed to either 1.0μg MK/ml or to the solvent only. The exposure time was 28h.</note>
<note type="content">Table 1: Effect of MK on MN frequencies in human Hep G2 cellsa</note>
<note type="content">Table 2: Effect of MK on the induction of MN by B(a)P in human Hep G2 cells (simultaneous treatment)a</note>
<note type="content">Table 3: Effect of MK pre-treatment on the induction of MN by B(a)P in human Hep G2 cellsa</note>
</notesStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a" type="main" xml:lang="en">Musk ketone enhances benzo(a)pyrene induced mutagenicity in human derived Hep G2 cells</title>
<author xml:id="author-1">
<persName>
<forename type="first">Volker</forename>
<surname>Mersch-Sundermann</surname>
</persName>
<email>mersch@rumms.uni-mannheim.de</email>
<note type="correspondence">
<p>Corresponding author. Fax: +49-621-411278</p>
</note>
<affiliation>Department of Toxicology and Ecotoxicology, FB VI, University of Trier, 54286 Trier, Germany</affiliation>
</author>
<author xml:id="author-2">
<persName>
<forename type="first">Heidi</forename>
<surname>Schneider</surname>
</persName>
<affiliation>Faculty of Clinical Medicine Mannheim, Institute of Microbiology and Hygiene, University of Heidelberg, P.O. Box 100023, D-68135 Mannheim, Germany</affiliation>
</author>
<author xml:id="author-3">
<persName>
<forename type="first">Christian</forename>
<surname>Freywald</surname>
</persName>
<affiliation>Institute of Cancer Research, University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria</affiliation>
</author>
<author xml:id="author-4">
<persName>
<forename type="first">Cornelia</forename>
<surname>Jenter</surname>
</persName>
<affiliation>Faculty of Clinical Medicine Mannheim, Institute of Microbiology and Hygiene, University of Heidelberg, P.O. Box 100023, D-68135 Mannheim, Germany</affiliation>
</author>
<author xml:id="author-5">
<persName>
<forename type="first">Wolfram</forename>
<surname>Parzefall</surname>
</persName>
<affiliation>Faculty of Clinical Medicine Mannheim, Institute of Microbiology and Hygiene, University of Heidelberg, P.O. Box 100023, D-68135 Mannheim, Germany</affiliation>
</author>
<author xml:id="author-6">
<persName>
<forename type="first">Siegfried</forename>
<surname>Knasmüller</surname>
</persName>
<affiliation>Institute of Cancer Research, University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria</affiliation>
</author>
</analytic>
<monogr>
<title level="j">Mutation Research - Genetic Toxicology and Environmental Mutagenesis</title>
<title level="j" type="abbrev">MUTGEN</title>
<idno type="pISSN">1383-5718</idno>
<idno type="PII">S1383-5718(00)X0071-X</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="2001"></date>
<biblScope unit="volume">495</biblScope>
<biblScope unit="issue">1–2</biblScope>
<biblScope unit="page" from="89">89</biblScope>
<biblScope unit="page" to="96">96</biblScope>
</imprint>
</monogr>
<idno type="istex">1F861B2B2A2AD2EAEADEBDCB70FE9FEB7524F0E9</idno>
<idno type="DOI">10.1016/S1383-5718(01)00202-9</idno>
<idno type="PII">S1383-5718(01)00202-9</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>2001</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract xml:lang="en">
<p>Musk ketone is a widely used artificial fragrance which has been identified in human fatty tissue and milk. The mutagenic and comutagenic effects of this compound were studied in micronucleus tests with a human derived hepatoma cell line (Hep G2). Exposure of the cells to MK alone in the range between 5 and 5000ng/ml did not cause induction of MN. When the cells were treated simultaneously with MK (5–5000ng/ml) and 0.2μg/ml benzo(a)pyrene, no synergistic effects were detected; benzo(a)pyrene (B(a)P) itself caused an 1.5-fold increase of MN over the spontaneous background frequency (60 versus 39 MN/1000 binucleated cells). In a third experimental series, the cells were pretreated with MK for 28h and subsequently exposed to 0.2μg/ml B(a)P. In this case, a pronounced comutagenic effect was observed: The LOAEL for MK was 0.05μg/ml. With higher doses (0.5, 1.0 and 5.0μg MK/ml), a significant increase of B(a)P induced MN frequencies was measured, the induction rates being 50, 66, and 88%, respectively. Additional measurements of 7-ethoxyresorufin deethylase indicated that MK induces cytochrome P450 isoenzymes (1A1) which play a key role in the activation of B(a)P. The results of the present study show that MK amplifies the genotoxic effects of B(a)P in human derived cells and indicate that exposure of humans to MK might increase their susceptibility to the health hazards of B(a)P and other polycyclic aromatic hydrocarbons.</p>
</abstract>
<textClass xml:lang="en">
<keywords scheme="keyword">
<list>
<head>Abbreviations</head>
<item>
<term>AC, Arochlor 1254</term>
</item>
<item>
<term>B(a)P, benzo(a)pyrene</term>
</item>
<item>
<term>BNC, binucleated cell</term>
</item>
<item>
<term>DMEM, Dulbeccos minimal essential medium</term>
</item>
<item>
<term>DMSO, dimethylsulfoxide</term>
</item>
<item>
<term>EROD, 7-ethoxyresorufin-O-deethylase</term>
</item>
<item>
<term>GST, glutathione-S-transferase</term>
</item>
<item>
<term>LOAEL, lowest observed adverse effect level</term>
</item>
<item>
<term>M, mean</term>
</item>
<item>
<term>MK, musk ketone</term>
</item>
<item>
<term>MN, micronucleus</term>
</item>
<item>
<term>NM, nitro musk</term>
</item>
<item>
<term>PAH, polycyclic aromatic hydrocarbon</term>
</item>
<item>
<term>PB, phenobarbital</term>
</item>
<item>
<term>S.D., standard deviation</term>
</item>
<item>
<term>UDPGT, uridine-diphosphate-glucuronyl-transferase</term>
</item>
</list>
</keywords>
</textClass>
<textClass xml:lang="en">
<keywords scheme="keyword">
<list>
<head>Keywords</head>
<item>
<term>Hep G2/MN assay</term>
</item>
<item>
<term>Musk ketone</term>
</item>
<item>
<term>Benzo(a)pyrene</term>
</item>
<item>
<term>Comutagenic</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc>
<change when="2001-05-08">Modified</change>
<change when="2001">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/document/1F861B2B2A2AD2EAEADEBDCB70FE9FEB7524F0E9/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Elsevier, elements deleted: ce:floats; body; tail">
<istex:xmlDeclaration>version="1.0" encoding="utf-8"</istex:xmlDeclaration>
<istex:docType PUBLIC="-//ES//DTD journal article DTD version 4.5.2//EN//XML" URI="art452.dtd" name="istex:docType">
<istex:entity SYSTEM="gr1" NDATA="IMAGE" name="gr1"></istex:entity>
<istex:entity SYSTEM="gr2" NDATA="IMAGE" name="gr2"></istex:entity>
<istex:entity SYSTEM="gr3" NDATA="IMAGE" name="gr3"></istex:entity>
</istex:docType>
<istex:document>
<converted-article version="4.5.2" docsubtype="fla" xml:lang="en">
<item-info>
<jid>MUTGEN</jid>
<aid>400292</aid>
<ce:pii>S1383-5718(01)00202-9</ce:pii>
<ce:doi>10.1016/S1383-5718(01)00202-9</ce:doi>
<ce:copyright type="full-transfer" year="2001">Elsevier Science B.V.</ce:copyright>
</item-info>
<head>
<ce:title>Musk ketone enhances benzo(a)pyrene induced mutagenicity in human derived Hep G2 cells</ce:title>
<ce:author-group>
<ce:author>
<ce:given-name>Volker</ce:given-name>
<ce:surname>Mersch-Sundermann</ce:surname>
<ce:cross-ref refid="AFF1">
<ce:sup>a</ce:sup>
</ce:cross-ref>
<ce:cross-ref refid="CORR1">*</ce:cross-ref>
<ce:e-address>mersch@rumms.uni-mannheim.de</ce:e-address>
</ce:author>
<ce:author>
<ce:given-name>Heidi</ce:given-name>
<ce:surname>Schneider</ce:surname>
<ce:cross-ref refid="AFF2">
<ce:sup>b</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>Christian</ce:given-name>
<ce:surname>Freywald</ce:surname>
<ce:cross-ref refid="AFF3">
<ce:sup>c</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>Cornelia</ce:given-name>
<ce:surname>Jenter</ce:surname>
<ce:cross-ref refid="AFF2">
<ce:sup>b</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>Wolfram</ce:given-name>
<ce:surname>Parzefall</ce:surname>
<ce:cross-ref refid="AFF2">
<ce:sup>b</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>Siegfried</ce:given-name>
<ce:surname>Knasmüller</ce:surname>
<ce:cross-ref refid="AFF3">
<ce:sup>c</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:affiliation id="AFF1">
<ce:label>a</ce:label>
<ce:textfn>Department of Toxicology and Ecotoxicology, FB VI, University of Trier, 54286 Trier, Germany</ce:textfn>
</ce:affiliation>
<ce:affiliation id="AFF2">
<ce:label>b</ce:label>
<ce:textfn>Faculty of Clinical Medicine Mannheim, Institute of Microbiology and Hygiene, University of Heidelberg, P.O. Box 100023, D-68135 Mannheim, Germany</ce:textfn>
</ce:affiliation>
<ce:affiliation id="AFF3">
<ce:label>c</ce:label>
<ce:textfn>Institute of Cancer Research, University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria</ce:textfn>
</ce:affiliation>
<ce:correspondence id="CORR1">
<ce:label>*</ce:label>
<ce:text>Corresponding author. Fax: +49-621-411278</ce:text>
</ce:correspondence>
</ce:author-group>
<ce:date-received day="20" month="2" year="2001"></ce:date-received>
<ce:date-revised day="8" month="5" year="2001"></ce:date-revised>
<ce:date-accepted day="10" month="5" year="2001"></ce:date-accepted>
<ce:abstract>
<ce:section-title>Abstract</ce:section-title>
<ce:abstract-sec>
<ce:simple-para>Musk ketone is a widely used artificial fragrance which has been identified in human fatty tissue and milk. The mutagenic and comutagenic effects of this compound were studied in micronucleus tests with a human derived hepatoma cell line (Hep G2). Exposure of the cells to MK alone in the range between 5 and 5000
<ce:hsp sp="0.25"></ce:hsp>
ng/ml did not cause induction of MN. When the cells were treated simultaneously with MK (5–5000
<ce:hsp sp="0.25"></ce:hsp>
ng/ml) and 0.2
<ce:hsp sp="0.25"></ce:hsp>
μg/ml benzo(a)pyrene, no synergistic effects were detected; benzo(a)pyrene (B(a)P) itself caused an 1.5-fold increase of MN over the spontaneous background frequency (60 versus 39 MN/1000 binucleated cells). In a third experimental series, the cells were pretreated with MK for 28
<ce:hsp sp="0.25"></ce:hsp>
h and subsequently exposed to 0.2
<ce:hsp sp="0.25"></ce:hsp>
μg/ml B(a)P. In this case, a pronounced comutagenic effect was observed: The LOAEL for MK was 0.05
<ce:hsp sp="0.25"></ce:hsp>
μg/ml. With higher doses (0.5, 1.0 and 5.0
<ce:hsp sp="0.25"></ce:hsp>
μg MK/ml), a significant increase of B(a)P induced MN frequencies was measured, the induction rates being 50, 66, and 88%, respectively. Additional measurements of 7-ethoxyresorufin deethylase indicated that MK induces cytochrome P450 isoenzymes (1A1) which play a key role in the activation of B(a)P. The results of the present study show that MK amplifies the genotoxic effects of B(a)P in human derived cells and indicate that exposure of humans to MK might increase their susceptibility to the health hazards of B(a)P and other polycyclic aromatic hydrocarbons.</ce:simple-para>
</ce:abstract-sec>
</ce:abstract>
<ce:keywords class="abr" xml:lang="en">
<ce:section-title>Abbreviations</ce:section-title>
<ce:keyword>
<ce:text>AC, Arochlor 1254</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>B(a)P, benzo(a)pyrene</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>BNC, binucleated cell</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>DMEM, Dulbeccos minimal essential medium</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>DMSO, dimethylsulfoxide</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>EROD, 7-ethoxyresorufin-
<ce:italic>O</ce:italic>
-deethylase</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>GST, glutathione-
<ce:italic>S</ce:italic>
-transferase</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>LOAEL, lowest observed adverse effect level</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>M, mean</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>MK, musk ketone</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>MN, micronucleus</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>NM, nitro musk</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>PAH, polycyclic aromatic hydrocarbon</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>PB, phenobarbital</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>S.D., standard deviation</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>UDPGT, uridine-diphosphate-glucuronyl-transferase</ce:text>
</ce:keyword>
</ce:keywords>
<ce:keywords class="keyword" xml:lang="en">
<ce:section-title>Keywords</ce:section-title>
<ce:keyword>
<ce:text>Hep G2/MN assay</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>Musk ketone</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>Benzo(a)pyrene</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>Comutagenic</ce:text>
</ce:keyword>
</ce:keywords>
</head>
</converted-article>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>Musk ketone enhances benzo(a)pyrene induced mutagenicity in human derived Hep G2 cells</title>
</titleInfo>
<titleInfo type="alternative" lang="en" contentType="CDATA">
<title>Musk ketone enhances benzo(a)pyrene induced mutagenicity in human derived Hep G2 cells</title>
</titleInfo>
<name type="personal">
<namePart type="given">Volker</namePart>
<namePart type="family">Mersch-Sundermann</namePart>
<affiliation>E-mail: mersch@rumms.uni-mannheim.de</affiliation>
<affiliation>Department of Toxicology and Ecotoxicology, FB VI, University of Trier, 54286 Trier, Germany</affiliation>
<description>Corresponding author. Fax: +49-621-411278</description>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Heidi</namePart>
<namePart type="family">Schneider</namePart>
<affiliation>Faculty of Clinical Medicine Mannheim, Institute of Microbiology and Hygiene, University of Heidelberg, P.O. Box 100023, D-68135 Mannheim, Germany</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Christian</namePart>
<namePart type="family">Freywald</namePart>
<affiliation>Institute of Cancer Research, University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Cornelia</namePart>
<namePart type="family">Jenter</namePart>
<affiliation>Faculty of Clinical Medicine Mannheim, Institute of Microbiology and Hygiene, University of Heidelberg, P.O. Box 100023, D-68135 Mannheim, Germany</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Wolfram</namePart>
<namePart type="family">Parzefall</namePart>
<affiliation>Faculty of Clinical Medicine Mannheim, Institute of Microbiology and Hygiene, University of Heidelberg, P.O. Box 100023, D-68135 Mannheim, Germany</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Siegfried</namePart>
<namePart type="family">Knasmüller</namePart>
<affiliation>Institute of Cancer Research, University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="research-article" displayLabel="Full-length article"></genre>
<originInfo>
<publisher>ELSEVIER</publisher>
<dateIssued encoding="w3cdtf">2001</dateIssued>
<dateModified encoding="w3cdtf">2001-05-08</dateModified>
<copyrightDate encoding="w3cdtf">2001</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
</physicalDescription>
<abstract lang="en">Musk ketone is a widely used artificial fragrance which has been identified in human fatty tissue and milk. The mutagenic and comutagenic effects of this compound were studied in micronucleus tests with a human derived hepatoma cell line (Hep G2). Exposure of the cells to MK alone in the range between 5 and 5000ng/ml did not cause induction of MN. When the cells were treated simultaneously with MK (5–5000ng/ml) and 0.2μg/ml benzo(a)pyrene, no synergistic effects were detected; benzo(a)pyrene (B(a)P) itself caused an 1.5-fold increase of MN over the spontaneous background frequency (60 versus 39 MN/1000 binucleated cells). In a third experimental series, the cells were pretreated with MK for 28h and subsequently exposed to 0.2μg/ml B(a)P. In this case, a pronounced comutagenic effect was observed: The LOAEL for MK was 0.05μg/ml. With higher doses (0.5, 1.0 and 5.0μg MK/ml), a significant increase of B(a)P induced MN frequencies was measured, the induction rates being 50, 66, and 88%, respectively. Additional measurements of 7-ethoxyresorufin deethylase indicated that MK induces cytochrome P450 isoenzymes (1A1) which play a key role in the activation of B(a)P. The results of the present study show that MK amplifies the genotoxic effects of B(a)P in human derived cells and indicate that exposure of humans to MK might increase their susceptibility to the health hazards of B(a)P and other polycyclic aromatic hydrocarbons.</abstract>
<note type="content">Fig. 1: Chemical structure of musk ketone.</note>
<note type="content">Fig. 2: Induction of MN in Hep G2 cells by MK alone and in combination with B(a)P. Hep G2 cells were exposed (i) to different concentrations of MK for 28h (white bars), (ii) simultaneously to different MK concentrations and 0.2μg/ml B(a)P for 28h (hatched bars) or (iii) for 28h to different MK concentrations and subsequently to 0.2μg/ml B(a)P (black bars). After exposure, cells were cultivated for 24h in cytochalasin B supplemented medium, then the MN frequencies determined as described in the text. Three slides were prepared per experimental point and in total 1000 BNC were evaluated.</note>
<note type="content">Fig. 3: Effect of MK on the induction of EROD in Hep G2 cells: (a) the effect seen after exposure of the cells to different concentrations of MK; (b) the means±S.D. of three independent experiments in which the cells were exposed to either 1.0μg MK/ml or to the solvent only. The exposure time was 28h.</note>
<note type="content">Table 1: Effect of MK on MN frequencies in human Hep G2 cellsa</note>
<note type="content">Table 2: Effect of MK on the induction of MN by B(a)P in human Hep G2 cells (simultaneous treatment)a</note>
<note type="content">Table 3: Effect of MK pre-treatment on the induction of MN by B(a)P in human Hep G2 cellsa</note>
<subject lang="en">
<genre>Abbreviations</genre>
<topic>AC, Arochlor 1254</topic>
<topic>B(a)P, benzo(a)pyrene</topic>
<topic>BNC, binucleated cell</topic>
<topic>DMEM, Dulbeccos minimal essential medium</topic>
<topic>DMSO, dimethylsulfoxide</topic>
<topic>EROD, 7-ethoxyresorufin-O-deethylase</topic>
<topic>GST, glutathione-S-transferase</topic>
<topic>LOAEL, lowest observed adverse effect level</topic>
<topic>M, mean</topic>
<topic>MK, musk ketone</topic>
<topic>MN, micronucleus</topic>
<topic>NM, nitro musk</topic>
<topic>PAH, polycyclic aromatic hydrocarbon</topic>
<topic>PB, phenobarbital</topic>
<topic>S.D., standard deviation</topic>
<topic>UDPGT, uridine-diphosphate-glucuronyl-transferase</topic>
</subject>
<subject lang="en">
<genre>Keywords</genre>
<topic>Hep G2/MN assay</topic>
<topic>Musk ketone</topic>
<topic>Benzo(a)pyrene</topic>
<topic>Comutagenic</topic>
</subject>
<relatedItem type="host">
<titleInfo>
<title>Mutation Research - Genetic Toxicology and Environmental Mutagenesis</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>MUTGEN</title>
</titleInfo>
<genre type="journal">journal</genre>
<originInfo>
<dateIssued encoding="w3cdtf">20010822</dateIssued>
</originInfo>
<identifier type="ISSN">1383-5718</identifier>
<identifier type="PII">S1383-5718(00)X0071-X</identifier>
<part>
<date>20010822</date>
<detail type="volume">
<number>495</number>
<caption>vol.</caption>
</detail>
<detail type="issue">
<number>1–2</number>
<caption>no.</caption>
</detail>
<extent unit="issue pages">
<start>1</start>
<end>172</end>
</extent>
<extent unit="pages">
<start>89</start>
<end>96</end>
</extent>
</part>
</relatedItem>
<identifier type="istex">1F861B2B2A2AD2EAEADEBDCB70FE9FEB7524F0E9</identifier>
<identifier type="DOI">10.1016/S1383-5718(01)00202-9</identifier>
<identifier type="PII">S1383-5718(01)00202-9</identifier>
<accessCondition type="use and reproduction" contentType="copyright">©2001 Elsevier Science B.V.</accessCondition>
<recordInfo>
<recordContentSource>ELSEVIER</recordContentSource>
<recordOrigin>Elsevier Science B.V., ©2001</recordOrigin>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Rhénanie/explor/UnivTrevesV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001505 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001505 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Rhénanie
   |area=    UnivTrevesV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:1F861B2B2A2AD2EAEADEBDCB70FE9FEB7524F0E9
   |texte=   Musk ketone enhances benzo(a)pyrene induced mutagenicity in human derived Hep G2 cells
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Jul 22 16:29:01 2017. Site generation: Wed Feb 28 14:55:37 2024